NCT06253715: Shortened Regimen for Drug-susceptible TB in Children
- State
- Under way
- Phase
- Phase 3
- People
- 860 planned
- Started
- 15 Jan 2025
- Primary completion
- 30 Sep 2027
- Arms
- Regimen 2: Isoniazid (H), Rifapentine (P), Pyrazinamide (Z), Moxifloxacin (M)
- Results
- None posted
- 12 Feb 2024: Trial registered
- 15 Jan 2025: Trial started